Clinical Trial Update: Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SU011248 for safety and effectiveness in patients with non-small cell lung cancer and brain metastases has completed, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SU011248

Snippet

Sponsor: Pfizer | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-02-24